"Our enterprise has grown to a size that requires a new management structure. We are thus moving away from a conservative management model towards a corporate model. For the first time in the history of our company, it will not be based on family members, but rather we will fill these management positions with executives with a proven track record. Most of whom have gathered long years of experience in our own company." - Christian O. Erbe
Christian O. Erbe (CEO)
President and Chief Executive Officer (CEO)
Daniel Zimmermann (CFO/CCO)
Executive Management, CFO (Chief Financial Officer), CCO (Chief Compliance Officer)
"By implementing this new organizational structure, we want to give the enterprise a stronger international orientation and utilize our potential to generate even greater growth."
Marcus Felstead (CMO)
Executive Management, CMO (Chief Marketing Officer)
"I see my role here as a networker. Restructuring will help us network various areas at Erbe in better ways. This will accelerate decision-making processes in the operative business of the Erbe Group. We have our customers and partners all over the world and align ourselves accordingly."
Dr. Helmut Scherer (CTO)
Executive Management, CTO (Chief Technology Officer)
"Through this restructuring measure we want to ensure that our customers continue to be supplied with innovative, high-quality products
on schedule. To this aim, we as managing executives will collaborate closely and develop the processes necessary for achieving this."
Prof. Dr. med. Markus D. Enderle (CSMO)
Executive Management, Chief Scientific and Medical Officer (CSMO)
"Our market is the entire world. As an enterprise we must prove the added value of our products. We provide clinical evidence on an international
scale. We have already set the course for this and are in the process of building on these foundations."